TSCA Questions for US Importers of Custom Chemical Blends: Build a Decision Record

A custom chemical blend can be straightforward to order and difficult to assess. Commercial labels such as “proprietary formulation,” “process additive” or “customer blend” do not identify the individual chemical substances that may need review under the Toxic Substances Control Act (TSCA). For a TSCA custom chemical blend importer checklist, begin before a shipment is booked: establish the importer of record, define the exact blend identity and intended use, obtain enough component-level evidence for the responsible party to make its assessment, and preserve the decision with the order and entry documents.

This article is a procurement and quality-control framework, not a TSCA determination or customs advice. Whether TSCA applies, whether an exclusion or exemption is relevant, whether a substance is existing or new, and which conditions apply depend on the exact facts. EPA explains that importing is included in manufacturing for TSCA purposes. The responsible importer should obtain competent regulatory and customs advice for the proposed transaction and should not rely on a supplier’s informal “TSCA compliant” statement as a replacement for its own documented review.

Define the transaction before screening a chemical

Start the decision record with the importer of record, seller, manufacturer, country of origin, consignee, product code, full blend revision, intended use, expected quantity, shipment timing and whether the product will be imported in bulk or as part of a mixture. Capture a technical identity package appropriate to the review: CAS Registry Numbers or other chemical identifiers where available, composition or confidential component information through an agreed controlled channel, concentration ranges, impurities or additives that may matter, SDS revision, and any restrictions communicated by the supplier.

EPA’s TSCA Inventory page states that the Inventory is the list of chemical substances manufactured or processed, including imports, for uses under TSCA, and that deciding whether a substance is on it is a critical step before starting manufacture, which includes import. A blend name is not an Inventory identity. For an imported mixture, the analysis needs to reach the individual component chemical substances to the extent relevant to the applicable requirements. Protect confidential information, but do not let commercial confidentiality create a blank decision record.

Keep the record with the controlled-document system and link it to the proposed custom chemical route. The buyer can request information through an appropriate confidentiality process; it should not publish a formula, confidential identity or supplier-specific data on a quotation or public webpage.

Distinguish an Inventory check from a complete compliance conclusion

The Inventory can help distinguish an existing from a new chemical substance under TSCA, but it is not a universal approval list for every commercial use. EPA notes that the Inventory contains flags for existing substances subject to manufacturing or use restrictions. A result should therefore lead to a documented review of applicable rules, orders, consent orders, significant new use rules or other conditions—not to a generic clearance statement.

For confidential identities, EPA describes a bona fide intent to manufacture or import notice that may allow a person with a genuine commercial intent to seek a written Inventory-status determination. The process requires specified identity and commercial-intent information, and can involve a supplier support letter where identity information is withheld. This is an example of why the purchasing team should start early: a last-minute request for an unknown proprietary component may not be compatible with the desired shipment date.

Document what was checked, by whom, on which date, using which product and composition revision, and what follow-up was required. Avoid recording “on the TSCA list” as the final answer. Instead, record the scope: component identity established or pending; Inventory-status route; restriction-screening owner; applicable certification decision; and approval or hold status. This makes the TSCA Inventory custom blend screening review auditable when a supplier changes formulation or a new lot is offered.

Screen new-chemical and import-certification questions early

EPA says that a person intending to manufacture or import a new chemical substance for a non-exempt commercial purpose must submit a premanufacture notice (PMN) at least 90 days before initiating the activity. EPA also states that importers of new chemicals must certify under TSCA section 13 that the chemical substances in the shipment comply with applicable TSCA rules or orders. These statements describe important decision points; they do not mean that every custom blend needs a PMN, or that a buyer may decide an exclusion without analysing the facts.

Use a short gate at quotation and purchase-order release: Is the intended transaction within TSCA scope? Has each relevant component identity been established under a protected process? Is the component existing, new, confidential-pending or subject to an identified condition? Is a PMN or another pathway being evaluated by the responsible party? Who is preparing any entry certification, and what document supports it? If any answer is unresolved, hold the import release rather than substituting an assumption.

EPA’s importer guidance also explains that importers of chemical substances, mixtures or articles are generally subject to TSCA requirements, while scope and regulatory treatment can differ. Treat an imported article, a mixture and a bulk substance as different fact patterns. A freight forwarder, customs broker or laboratory may assist operationally, but contractual delegation does not eliminate the importer’s need to know who owns the compliance decision.

Use supplier evidence without over-relying on it

Ask the supplier for a controlled technical statement tied to the exact blend revision and manufacturing location. Useful elements can include product and revision identification, component identity access route, concentration ranges, SDS and classification revision, known regulatory flags communicated for the intended US use, confirmation of any formulation change since the last approved shipment, and an authorised contact for technical follow-up. These are evidence requests, not a demand to disclose protected know-how in an uncontrolled email.

Separate supplier-provided information from the importer’s conclusion. A certificate that says “TSCA listed” may be incomplete if it does not identify the blend revision, component scope, date, intended use or conditions considered. Conversely, absence of a public component list does not prove non-compliance. The decision record should state what was received, what remains confidential, what screening method is authorised and whether the responsible party has approved import of that configuration.

At receiving, match the delivered label, product code, lot, pack, SDS and commercial documents to the approved configuration. If the shipment is described as a different product, blend revision or manufacturing site, treat it as a change. Link the result to lot traceability so later technical findings or regulatory questions can be traced back to the identity and decision current at import.

Control formula and supply-route changes

A custom blend is not stable merely because its trade name remains unchanged. Set change-notification triggers for component identity, CAS identifier, composition range, impurity profile, additive, manufacturing location, production route, product code, SDS, intended use, package, importer of record and destination. Require notice early enough for the responsible party to decide whether a fresh TSCA review, customer qualification, entry-document change or other action is needed.

Keep roles clear: procurement owns commercial timing and completeness of the request; technical or regulatory personnel own the review and conclusion; logistics coordinates only after release; quality maintains the controlled evidence; and the importer of record owns the applicable entry responsibility. The North American market route and testing support can help frame product and quality questions, but they do not replace the importer’s regulatory analysis.

Custom-blend importer checklist

• Identify the importer of record, intended use, shipment form, quantity and blend revision.
• Obtain a controlled component-identity route that protects confidential information.
• Screen each relevant component’s Inventory status and any identified restrictions or conditions.
• Keep an explicit record of scope, evidence, reviewer, date, decision and outstanding questions.
• Evaluate PMN and section 13 certification questions before booking the import.
• Match product code, lot, pack, SDS and import documents to the approved configuration.
• Put formula, site, identity, SDS, pack and importer changes through documented review.
• Hold a transaction when identity or responsible approval remains unresolved.

A disciplined chemical blend import certification USA record helps procurement move a custom formulation through the right review gates without claiming a blanket regulatory conclusion. For a defined product and destination, review global supply planning, quality documentation support and request a custom-blend review with the intended use, shipment form and identity-access requirements.